# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001140361-23-034684
Filing Date
2023-07-17
Accepted
2023-07-17 07:23:27
Documents
35
Period of Report
2023-07-17
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | brhc20055953_8k.htm iXBRL | 8-K | 46690
2 | EXHIBIT 99.1 | brhc20055953_ex99-1.htm | EX-99.1 | 31256
3 | EXHIBIT 99.2 | brhc20055953_ex99-2.htm | EX-99.2 | 42315
7 |  | brhc20055953_ex99-2slide1.jpg | GRAPHIC | 195566
8 |  | brhc20055953_ex99-2slide2.jpg | GRAPHIC | 388654
9 |  | brhc20055953_ex99-2slide3.jpg | GRAPHIC | 70863
10 |  | brhc20055953_ex99-2slide4.jpg | GRAPHIC | 66118
11 |  | brhc20055953_ex99-2slide5.jpg | GRAPHIC | 70909
12 |  | brhc20055953_ex99-2slide6.jpg | GRAPHIC | 179873
13 |  | brhc20055953_ex99-2slide7.jpg | GRAPHIC | 154526
14 |  | brhc20055953_ex99-2slide8.jpg | GRAPHIC | 132664
15 |  | brhc20055953_ex99-2slide9.jpg | GRAPHIC | 178288
16 |  | brhc20055953_ex99-2slide10.jpg | GRAPHIC | 72274
17 |  | brhc20055953_ex99-2slide11.jpg | GRAPHIC | 150890
18 |  | brhc20055953_ex99-2slide12.jpg | GRAPHIC | 178624
19 |  | brhc20055953_ex99-2slide13.jpg | GRAPHIC | 162032
20 |  | brhc20055953_ex99-2slide14.jpg | GRAPHIC | 73347
21 |  | brhc20055953_ex99-2slide15.jpg | GRAPHIC | 90449
22 |  | brhc20055953_ex99-2slide16.jpg | GRAPHIC | 134540
23 |  | brhc20055953_ex99-2slide17.jpg | GRAPHIC | 70297
24 |  | brhc20055953_ex99-2slide18.jpg | GRAPHIC | 112478
25 |  | brhc20055953_ex99-2slide19.jpg | GRAPHIC | 71983
26 |  | brhc20055953_ex99-2slide20.jpg | GRAPHIC | 137923
27 |  | brhc20055953_ex99-2slide21.jpg | GRAPHIC | 174023
| Complete submission text file | 0001140361-23-034684.txt |  | 4229915

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL TAXONOMY EXTENSION SCHEMA | bbio-20230717.xsd | EX-101.SCH | 3868
5 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | bbio-20230717_lab.xml | EX-101.LAB | 22546
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | bbio-20230717_pre.xml | EX-101.PRE | 16046
29 | EXTRACTED XBRL INSTANCE DOCUMENT | brhc20055953_8k_htm.xml | XML | 4225

Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38959 | Film No.: 231090505
SIC: 2834 Pharmaceutical Preparations